ThermiRF Now Available in Australia and New Zealand
We are very excited to announce the Australian and New Zealand release of ThermiRF. Previously only available in the US, ThermiRF is a compact multi-platform system addressing localised fat melting, skin tightening and wrinkle reduction with both non-invasive and minimally invasive sub-cutaneous applications.
One of the unique features of the ThermiRF platform is its ability to safely and precisely heat the skin. Only with the ThermiRF procedure can the temperature of the tissues beneath the skin and at the surface be accurately controlled and safely monitored. This allows the maximum amount of heat to be delivered which results in increased collagen production and tightening.
Using a precise temperature-controlled radio frequency technology, Thermi™ has new and innovative products that will nip, tuck and tighten without any invasive surgery. These products will lift a sagging neck, smooth the lines around the mouth and eyes, fight your fat and cellulite and even help your sex life.
The ThermiRF system is used along with a tiny SmartTip thermistor probe, which is inserted under the skin to heat subdermal tissues to a specific user-selected temperature to smooth and tighten the skin, and promote collagen production.
ThermiSmooth is performed using a specially designed thermistor-regulated hand piece, which is supplied with the ThermiRF system. ThermiSmooth delivers precise heating to the skins surface. Clinical studies show that the collagen in skin will shrink when heated to sustained temperatures in excess of 40°C.
ThermiVa treatments deliver controlled thermal energy to the external labia and/or internal vaginal using the same technology as ThermiTight and ThermiSmooth procedures, reducing the effects of aging.
ThermiRase is a micro-invasive procedure based on a peer-reviewed protocol to disable the nerves which control the muscles responsible for glabella frown lines. This procedure applies radio frequency energy to selected nerves. In a recent study, the effect lasted more than one year in almost 80% of the subjects, thus validating the opportunity for a long-term alternative to neurotoxins.